HDAC9 and acute lymphoblastic leukemia: These findings are consistent with previous results describing a possible involvement of NF-κB as pro-apoptotic mediator in a panel of B-ALL cell lines, primary samples, and xenograft mouse models treated with a combination of bortezomib and HDAC inhibitors [22].